Compare OABI & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OABI | ABR |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 696.4M | 809.7M |
| IPO Year | 2021 | 2003 |
| Metric | OABI | ABR |
|---|---|---|
| Price | $4.90 | $2.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $8.33 | $3.25 |
| AVG Volume (30 Days) | 1.3M | ★ 7.9M |
| Earning Date | 10-30-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 22.52% |
| EPS Growth | ★ 6.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,666,000.00 | N/A |
| Revenue This Year | $87.73 | N/A |
| Revenue Next Year | $25.31 | $3.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.32 | $2.53 |
| 52 Week High | $5.43 | $10.10 |
| Indicator | OABI | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 22.80 |
| Support Level | $4.51 | N/A |
| Resistance Level | $5.06 | $5.38 |
| Average True Range (ATR) | 0.32 | 0.20 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 53.08 | 24.06 |
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.